NexImmune NexImmune is a biopharmaceutical company developing immunotherapy products based on the Artificial Immune Modulation nanotechnology platform. | ||
Founding Date | Founding Date 2013 | Founding Date 2011 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Dallas, US HQ | Locations Gaithersburg, US HQ |
Employees | Employees 241100% increase | Employees 5032% decrease |
Valuation ($) | Valuation ($) 37.6 m | Valuation ($) 372.4 k |
Financial | ||
Net income | Net income ($17.1m) (FY, 2025) | Net income ($32.3m) (FY, 2023) |
Funding | ||
Total funding raised | Total funding raised $ 4.7m | Total funding raised $ 33.8m |
NexImmune is a biopharmaceutical company developing immunotherapy products based on the Artificial Immune Modulation nanotechnology platform.
View company